Emergent BioSolutions Inc. — Director's Dealing 2020

Jan 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2020-01-16

Reporting Person: Harsanyi Zsolt (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-16	Common Stock	S	3435	$55	Disposed	36273	Direct

Footnotes

F1: Consists of restricted stock units granted the Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.

F2: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Harsanyi.